Please verify your age.
Only two molecules drive almost every UK cannabis prescription, yet the plant holds more than 100 cannabinoids. We look at why its pharmaceutical potential is still largely untapped, how dosing tolerances stack up, and what better delivery could unlock for patients.
Nine pharmacies, three Swiss cities and 1,177 cannabis users: the SCRIPT trial's interim data shows legal access nudging consumers toward vapes, exposing contaminated street product and raising almost no police concerns. Here's what the numbers mean for growers and regulators.
Europe’s cannabis market is changing, but its health impact remains uncertain. Stronger resin, new products and diverging national laws complicate the picture. Here’s what the latest EUDA evidence reveals—and what the figures cannot tell us about use and harm.
From Germany's Cannabis Act to Spain's hospital pharmacies, Europe is rewriting the rules on cannabis medicine. We unpack the 17.6% CAGR behind a fourfold rise in market value, the segments pulling ahead, from indica flower to CBD oils, and the barriers still slowing patient access.
Germany's prices are tumbling, the UK's patient count is climbing and Portugal is shipping tonnes across the continent. We break down the figures behind Europe's fastest-moving cannabis markets, from Swiss pilot trials to the 2029 forecasts, and what it all means for growers.
Germany's April 2024 reform legalised possession and home growing but never built a legal market. We look at what two years of real-world data reveal: why home cultivation thrived, why the social clubs stalled, how medical prescriptions exploded, and what growers elsewhere should take from it.
More than 1,000 medicinal cannabis products sit on pharmacy shelves, but only two have ever passed full regulatory assessment. We look at how special access pathways became the norm, what that gap means for patients and prescribers, and why honest genetics matter more than ever.
Our Cannabis Blog is a rich knowledge base built about lifestyle, culture, world politics but also seeds and strains, genetics, effects of use, and everyday questions people have about recreational cannabis. We publish easy-to-read primers, “facts about cannabis” summaries, and deep dives into e.g. how cannabinoids such as THC and CBD work as compounds.
You’ll also see concise medical marijuana news and cannabis industry (cannabis business) news with short analysis, so you can follow the latest news without noise. When a study finds something new about cannabis use (cannabis consumption) — say, how inhalation compares with other routes — we show the methods, the result, and what the data may mean in practice. We read research (and other cannabis news) so you don’t have to.
The Shottas® Blog is a space for clear answers to real-world questions. Expect how-to guides for beginner growers, indoor vs. outdoor growing comparisons, and cannabis strain reviews that describe aroma, flavor and effect in straightforward terms.
We also track the business side of the industry: product reviews and the occasional product launch or hearings and executive proposals. We summarise research and link to trustworthy information so you can stay open to recent developments.
Whether you’re an experienced grower or just getting started, you’ll feel at home here. If you value facts, plain language, and an international point of view, this blog is for you.
Our audience includes collectors, hobbyists, and readers who want reliable coverage of cannabis without drama — people who prefer no-nonsense explanations backed by research and real-world experience.
Enjoy the reading. Let Shottas Blog® become your regular stop on the green road. Marijuana connects people across the world, and our stories, guides, and analysis keep you informed about the latest changes and trends. We explore cannabis as a plant and a culture — clearly, calmly, and with respect for local rules.
Shottas operates internationally. Laws differ by country and region; in some places, possession of seeds is legal while cultivation of cannabis may not be. We do not encourage illegal drug activity. All content is educational, for information only, and intended for adults. Always check local regulations before any use. Nothing here is medical advice or a substitute for care; our articles discuss research, policy, and market context only. If regulations change — whether through a hearing, an agency’s final rule, or a ruling that leads to an increase in enforcement — please rely on official sources in your area and consult professionals where appropriate.
Europe